GlassScriptPhysician profile
William R Barnard
NPI 1396742110
$996.15
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $82.75 · 2021: $359 · 2022: $101.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $142.77 | 2019-2022 | |
| Novo Nordisk INC | $114.49 | 2019-2021 | |
| Amgen INC. | $111.31 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $85.88 | 2019-2022 | |
| Shire North American Group INC | $61.00 | 2019 | |
| Lilly USA, LLC | $57.82 | 2021 | |
| Adlon Therapeutics L.P. | $52.10 | 2019-2021 | |
| Pfizer INC. | $48.14 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.14 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $37.87 | 2021 | |
| Ironshore Pharmaceuticals INC. | $33.69 | 2019-2020 | |
| Antares Pharma, INC. | $29.03 | 2019 | |
| Glaxosmithkline, LLC. | $23.36 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.60 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.17 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.75 | 2022 | |
| Amarin Pharma, INC. | $15.29 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.01 | 2019 | |
| Allergan, INC. | $14.66 | 2020 | |
| Phadia US INC. | $14.26 | 2019 | |
| Intersect Ent, INC. | $12.06 | 2019 | |
| Genentech USA, INC. | $11.86 | 2019 | |
| Nevro Corp. | $11.70 | 2019 | |
| Upsher-Smith Laboratories LLC | $11.19 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Barnard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.